Literature DB >> 10214752

Quantitative analysis of epidermal innervation in Fabry disease.

L J Scott1, J W Griffin, C Luciano, N W Barton, T Banerjee, T Crawford, J C McArthur, A Tournay, R Schiffmann.   

Abstract

OBJECTIVE: To use skin biopsy specimens to quantitate the cutaneous innervation density of Fabry patients who had preserved renal function.
BACKGROUND: The small fiber neuropathy of Fabry disease is difficult to detect and quantitate by conventional methods. Because this neuropathy is a common characteristic of Fabry disease, quantitating changes in this parameter would be helpful in demonstrating the effectiveness of enzyme or gene replacement therapy.
METHODS: Patients underwent skin biopsy at the thigh and foot. Innervation density was determined by counting free nerve endings in the epidermis. These data were compared with nerve conduction studies, and in selected patients, fiber quantitation of sural nerve biopsy specimens.
RESULTS: The Fabry patients had normal results of nerve conduction studies and large fiber quantitation by sural nerve biopsy. However, the involvement of small cutaneous fibers in these patients was easily demonstrable and quantifiable by skin biopsy. All patients showed severe loss of intraepidermal innervation at the ankle, but fiber loss at the distal thigh was proportionately less severe.
CONCLUSIONS: The nerve damage in Fabry patients with preserved renal function involves exclusively small myelinated and unmyelinated fibers, and skin biopsy is a useful in detecting and quantitating such damage. Comparison of cutaneous innervation density with quantitation of sural nerve biopsy specimens demonstrated that skin biopsy specimens were as sensitive in detecting the presence of neuropathy as were the nerve specimens. It is speculated that analysis of cutaneous innervation may provide a useful marker of the nervous system's response to specific therapy for Fabry disease.

Entities:  

Mesh:

Year:  1999        PMID: 10214752     DOI: 10.1212/wnl.52.6.1249

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  24 in total

Review 1.  Small-fibre neuropathies--advances in diagnosis, pathophysiology and management.

Authors:  Janneke G Hoeijmakers; Catharina G Faber; Giuseppe Lauria; Ingemar S Merkies; Stephen G Waxman
Journal:  Nat Rev Neurol       Date:  2012-05-29       Impact factor: 42.937

Review 2.  Fabry disease: a rare cause of neuropathic pain.

Authors:  Marieke Biegstraaten; Gabor E Linthorst; Ivo N van Schaik; Carla E M Hollak
Journal:  Curr Pain Headache Rep       Date:  2013-10

3.  A quantitative method for the assessment of intraepidermal nerve fibers in small-fiber neuropathy.

Authors:  Mika Koskinen; Aki Hietaharju; Maarit Kyläniemi; Jukka Peltola; Immo Rantala; Bjarne Udd; Hannu Haapasalo
Journal:  J Neurol       Date:  2005-03-29       Impact factor: 4.849

4.  Comparison of a simple method for quantitation of intraepidermal nerve fibres with a standard image analysis method using hypothenar skin.

Authors:  Einar P V Wilder-Smith; Adeline Chow
Journal:  J Neurol       Date:  2006-06-19       Impact factor: 4.849

5.  [Fabry's disease: new therapeutic options for this lysosomal storage disorder].

Authors:  A J Grau; M Schwaninger; H H Goebel; M Beck
Journal:  Nervenarzt       Date:  2003-05-20       Impact factor: 1.214

6.  Epidermal nerve fibers: confidence intervals and continuous measures with nerve conduction.

Authors:  JaNean K Engelstad; Sean W Taylor; Lawrence V Witt; Belinda J Hoebing; David N Herrmann; P James B Dyck; Christopher J Klein; David M Johnson; Jenny L Davies; Rickey E Carter; Peter J Dyck
Journal:  Neurology       Date:  2012-10-24       Impact factor: 9.910

7.  Functional interactions between tumor and peripheral nerve: changes in excitability and morphology of primary afferent fibers in a murine model of cancer pain.

Authors:  D M Cain; P W Wacnik; M Turner; G Wendelschafer-Crabb; W R Kennedy; G L Wilcox; D A Simone
Journal:  J Neurosci       Date:  2001-12-01       Impact factor: 6.167

8.  Development of a model system for neuronal dysfunction in Fabry disease.

Authors:  Christine R Kaneski; Roscoe O Brady; John A Hanover; Ulrike H Schueler
Journal:  Mol Genet Metab       Date:  2016-07-22       Impact factor: 4.797

9.  Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males.

Authors:  K D MacDermot; A Holmes; A H Miners
Journal:  J Med Genet       Date:  2001-11       Impact factor: 6.318

10.  Autonomic neuropathy in Fabry disease: a prospective study using the Autonomic Symptom Profile and cardiovascular autonomic function tests.

Authors:  Marieke Biegstraaten; Ivo N van Schaik; Wouter Wieling; Frits A Wijburg; Carla E M Hollak
Journal:  BMC Neurol       Date:  2010-06-07       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.